We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

84 hedge funds and large institutions have $31.7M invested in Tempest Therapeutics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

5% more funds holding

Funds holding: 80 → 84 (+4)

85% less capital invested

Capital invested by funds: $206M → $31.7M (-$175M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $38K

Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
21
Reduced
13
Closed
16
Calls
–
Puts
$38K
Net Calls
-$38K
Net Calls Change
+$49K

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$1.77M
2
Millennium Management
Millennium Management
New York
+$1.57M
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$1.32M
4
Morgan Stanley
Morgan Stanley
New York
+$473K
5
AIC
AWM Investment Company
New York
+$424K

Top Sellers

Rank Fund Capital Flow
1
OAG
Orbis Allan Gray
Bermuda
-$18.9M
2
JHIU
Janus Henderson Investors US
Colorado
-$16.4M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$12.1M
4
Jennison Associates
Jennison Associates
New York
-$3.31M
5
Asset Management One
Asset Management One
Japan
-$2.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$186K +$137K +11 +37%
HCM
27
Howland Capital Management
Massachusetts
$180K – – –
SSA
28
Schonfeld Strategic Advisors
New York
$153K +$386K +31 +1,033%
TCIM
29
TIAA CREF Investment Management
New York
$148K – – –
Deutsche Bank
30
Deutsche Bank
Germany
$141K -$473K -38 -54%
CS
31
Credit Suisse
Switzerland
$138K +$274K +22 +244%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$138K +$287K +23 +288%
ERSOT
33
Employees Retirement System of Texas
Texas
$137K – – –
Goldman Sachs
34
Goldman Sachs
New York
$121K +$249K +20 +286%
TA
35
Teachers Advisors
New York
$104K +$99.7K +8 +53%
Jane Street
36
Jane Street
New York
$101K +$287K +23 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$99K -$12.5K -1 -4%
Charles Schwab
38
Charles Schwab
California
$87K -$24.9K -2 -10%
ID
39
Integral Derivatives
New York
$86K +$237K +19 New
Connor, Clark & Lunn Investment Management (CC&L)
40
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$83K +$237K +19 New
AllianceBernstein
41
AllianceBernstein
Tennessee
$77K – – –
SIP
42
Stoneridge Investment Partners
Pennsylvania
$76K – – –
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$74K – – –
SM
44
Sabby Management
Florida
$74K – – –
NCMW
45
Northern Capital Management (Wisconsin)
Wisconsin
$73K +$137K +11 +220%
Swiss National Bank
46
Swiss National Bank
Switzerland
$68K – – –
OC
47
Oppenheimer & Co
New York
$66K -$49.8K -4 -21%
CA
48
Commerzbank Aktiengesellschaft
Germany
$63K +$87.2K +7 +100%
PP
49
PDT Partners
New York
$57K -$174K -14 -52%
DTL
50
Dynamic Technology Lab
Singapore
$56K +$162K +13 New
1
2
3 4 5

TPST Hedge Fund Activity: Q4 2016 in Review

84 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2016, worth a combined $31.7M — down 85% from $206M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TPST positions and 16 closed out — a net gain of 4 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $1.77M. The largest seller was Orbis Allan Gray, exiting entirely with an estimated $18.9M sold.

  • 84 institutional investors held Tempest Therapeutics (TPST) as of Q4 2016, up from 80 in Q3 2016.
  • Funds reported $31.7M of Tempest Therapeutics stock for Q4 2016, down 85% quarter-over-quarter.
  • 20 funds opened new Tempest Therapeutics positions in Q4 2016 and 16 closed out, a net change of +4 holders.
  • The largest Tempest Therapeutics buyer in Q4 2016 was Anson Funds Management, an estimated $1.77M added.
  • The largest Tempest Therapeutics seller in Q4 2016 was Orbis Allan Gray, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2016.